Non-Muscle Invasive Bladder Cancer Resistant to Bcg

Basit Öğe Kaydı
dc.authorwosidTürkeri, Levent N./W-9283-2018
dc.contributor.authorTürker, Polat
dc.contributor.authorTürkeri, Levent
dc.date.accessioned2022-05-11T14:36:57Z
dc.date.available2022-05-11T14:36:57Z
dc.date.issued2013
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Üroloji Ana Bilim Dalı
dc.description.abstractTreatment options for patients with non-muscle invasive bladder cancer (NM/BC) refractory to intravesical bacillus Calmette-Guerin (BCG) therapy is reviewed in this article based on the recent published literature. Although intravesical BCG is the best bladder sparing treatment option for NM/BC to prevent recurrence and progression, about 1/3 of cases are refractory to this treatment. At this point radical cystectomy is the standard treatment of choice. If this option is not feasible, intravesical chemotherapy with docetaxel or gemcitabine, the combination of BCG and interferon (INF)-alpha or device-assisted intravesical strategies, such as mitomycin-EMDA or chemohyperthermia are some of the candidates for further treatment.
dc.identifier.endpage840
dc.identifier.issn0004-0614
dc.identifier.issn1576-8260
dc.identifier.issue9en_US
dc.identifier.pmid24231293
dc.identifier.startpage833
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8501
dc.identifier.volume66
dc.identifier.wosWOS:000326952700001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.institutionauthorTürker, Polat
dc.language.isoes
dc.publisherIniestares, S.A.
dc.relation.ispartofArchivos Espanoles De Urologia
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectNon-muscle invasive bladder cancer
dc.subjectBCG failure
dc.subjectItravesical therapy
dc.subjectBacillus-Calmette-Guerin
dc.subjectTransitional-Cell Carcinoma
dc.subjectPhase-Ii Trial
dc.subjectMitomycin-C
dc.subjectRadical Cystectomy
dc.subjectIntravesical Chemotherapy
dc.subjectElectromotive Mitomycin
dc.subject5-Aminolevulinic Acid
dc.subjectUrothelial Carcinoma
dc.subjectPlus Interferon
dc.titleNon-Muscle Invasive Bladder Cancer Resistant to Bcg
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Tıp Fakültesi Koleksiyonu